Whether the extent of residual disease in the sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC) influences the prognosis in clinically node-positive breast cancer (BC) patients remains to be ascertained.

Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients

Tinterri, Corrado;
2021

Abstract

Whether the extent of residual disease in the sentinel lymph node (SLN) after neoadjuvant chemotherapy (NAC) influences the prognosis in clinically node-positive breast cancer (BC) patients remains to be ascertained.
Breast cancer
Breast-related recurrences
Clinically-positive axillary nodes
Neoadjuvant chemotherapy
Sentinel lymph node
Survival
Adult
Aged
Aged, 80 and over
Axilla
Biopsy, Fine-Needle
Breast Neoplasms
Carcinoma, Ductal, Breast
Carcinoma, Lobular
Disease-Free Survival
False Negative Reactions
Female
Humans
Incidence
Lymph Node Excision
Lymph Nodes
Middle Aged
Neoplasm Micrometastasis
Neoplasm Recurrence, Local
Neoplasm, Residual
Sentinel Lymph Node
Sentinel Lymph Node Biopsy
Survival Rate
Neoadjuvant Therapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/66787
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact